Barrier Integrity Index

The Barrier Integrity Index is the analytical framework against which Hydra Chronic conducts its assessments.

It evaluates whether a formulation is physiologically coherent for compromised skin barriers – not whether it performs well in general, but whether its component logic holds under the specific conditions of barrier-impaired skin.

Assessments are conducted across four dimensions. Each dimension is evaluated independently against criteria derived from peer-reviewed dermatological and pharmaceutical literature. The result is a documented verdict.

The four dimensions:

Barrier architecture – whether the lipid matrix is structurally coherent with the lamellar requirements of compromised skin

Functional pH corridor – whether the formulation operates within the pH range that prevents serine protease overactivation in compromised barriers.

Membrane compatibility – whether the formulation is free of components that extract lipids, disrupt membrane integrity, or sensitise compromised barrier systems.

Delivery logic – whether active components are positioned to reach their intended site of action under barrier-compromised conditions.

The Signet

A formulation that meets the criteria across all four dimensions receives the Hydra Chronic Signet.

A formulation that demonstrates exceptional coherence – where the component architecture reflects active barrier support rather than passive compatibility – receives the Signet Distinction.

What does not meet the criteria receives no public statement.